Wontech Co.

What Wontech Co. does

Wontech Co., Ltd. is a South Korea-based medical device manufacturer (KOSDAQ: 336570, founded 1999, headquartered in Daejeon) specializing in laser and energy-based systems for aesthetic and surgical applications. The company independently designs and manufactures both the laser source and the power supply system in-house — a vertical integration uncommon in the industry — producing a portfolio that includes monopolar RF devices (Oligio, Oligio X, Oligio Kiss, Tightan), picosecond and Q-switched lasers (Picocare Majesty, PicoAlex, PicoAndy, Pastelle Pro), thulium lasers (Lavieen), dual-wavelength hybrid systems (Sandro Dual), vascular lasers (V-Laser, VeinCare), and holmium surgical lasers (HOLINWON PRIMA and PRO). In 2026 it extended into biometric monitoring (PETRA & LIME) and AI-assisted pain therapy (ELLISE) at CES, and began development of consumer-grade OligioHome devices for the home beauty market.

Wontech sells primarily to dermatologists, plastic surgeons, aesthetic MedSpas, and urology/surgical hospital departments, using a hybrid direct-and-distributor model through four wholly-owned regional subsidiaries (USA, Japan, China, Thailand/Asia) and channel partners in 80+ countries. Revenue is generated through one-time capital equipment sales (Oligio X US MSRP $85,000) supplemented by a growing recurring consumables/tips stream (KRW 74 billion in Q1 2026) tied to the installed base. Consolidated 2025 revenue reached KRW 1,568 billion (~$1.1 billion) with a 33% operating margin and a 77.5% export ratio; Q1 2026 revenue of KRW 402 billion grew 7.6% YoY with gross margin expanding to 71.1%.

The company is co-led by CEOs Kim Jong-won and Kim Jung-hyun and is positioning for a strategic shift from a technology-driven manufacturer to a global consumer-facing brand, funded in part by a KRW 75 billion convertible bond from PACM Private Equity (May 2026) and supported by an executive bench drawn from Samsung Electronics, HP, Cutera, and Jeisys Medical. Recent milestones include MSCI Global Small Cap Index inclusion (2023), a US FDA-approved Holinwon Prima (Asia's first FDA-cleared holmium surgical laser), and three consecutive years of #1 consumer preference ranking in Korea for the Oligio brand.

Name

Wontech Co.

Legal name

원텍 주식회사 (Wontech Co., Ltd.)

Website

https://wtlaser.com

Company type

Public

Founded year

1999

Operating status

Operating

Headcount range

51–100 employees

Short description

Wontech Co. is a South Korean medical device manufacturer (KOSDAQ: 336570) that vertically integrates laser and energy-based systems — including the Oligio RF, Picocare picosecond, Lavieen thulium, and Holinwon holmium product lines — for dermatologists, plastic surgeons, MedSpas, and surgical hospitals across 80+ countries.

Ownership category

akta.pro rank

Product category

Medical Aesthetic Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical and Medical Instrument Manufacturing (339112)

SIC

Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Laser & Energy-Based Dermatology (HLAKACAF)

akta.pro secondary industries

Energy-Based Surgical Devices (Electrosurgery, RF, Ultrasonic, Laser) (HLAHADAC), Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS) (HLAHADAA)

Keywords

• Medical aesthetic devices
• Laser medical equipment
• Energy-based devices
• Surgical laser systems
• RF aesthetic platforms

Headquarters

HQ city

Daejeon

HQ country

South Korea

HQ region

Asia

Offices7 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Supply Chain, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Equipment Sales: Sale of laser and energy-based medical devices including Oligio series, Picocare, Lavieen, Sandro Dual, V-Laser, and Holinwon surgical devices. One-time capital equipment sales with varying price points.
2. Consumables (Tips): Recurring consumable revenue from proprietary tips and cartridges used with equipment. Q1 2026 consumables sales reached 74 billion KRW, representing stable recurring revenue stream following equipment sales.
3. Home Beauty Devices: Planned entry into consumer market with Oligio Home branded home beauty devices. Strategy to expand from B2B to B2C direct customer engagement through consumer product line.

Pricing tiers

Go-to-market motion3 records

Distribution channels5 records

Marketing channels7 records

Core offering

Wontech designs, manufactures, and sells laser and energy-based medical devices for aesthetic and surgical applications. Its portfolio includes monopolar/bipolar RF lifting systems (Oligio family), picosecond pigment lasers (PicoAlex, PicoAndy, PicoCare), thulium and holmium surgical lasers (Lavieen, HOLINWON series), Q-switched and dual-wavelength platforms (Sandro Dual, Pastelle PRO), and dedicated vascular and tightening systems (VeinCare, Tightan, V-Laser), sold to clinics, hospitals, and licensed medical professionals in 80+ countries.

Product overview

Wontech Co., Ltd. is a South Korean medical device company specializing in laser and energy-based technologies for medical aesthetics and surgical applications. The product portfolio includes: RF-based aesthetic devices (Oligio, Oligio X, Oligio Kiss, Tightan), picosecond lasers (PicoAlex, PicoAndy, Picocare Majesty), thulium lasers (Lavieen), hybrid laser systems (Sandro Dual), Q-switched lasers (Pastelle, Pastelle PRO), vascular lasers (V-Laser, VeinCare), and holmium surgical lasers (HOLINWON PRO, HOLINWON PRIMA). The company also offers home beauty devices and healthcare solutions including PETRA & LIME biometric monitoring and ELLISE pain treatment platform. Products serve dermatologists, plastic surgeons, MedSpa owners, and urologists across 80+ countries.

Differentiator

Problem solved

Functional benefit

Brands

• Oligio: Monopolar RF device for skin lifting and tightening; flagship product line including Oligio, Oligio X, and Oligio KISS variants.
• Lavieen
• Picocare
• Sandro Dual
• Pastelle Pro
• Tightan
• V-Laser
• HOLINWON (홀인원)
• VeinCare
• WONTECH MALL
• Wave

Products and services

• Oligio X
• Oligio
• Oligio Kiss
• Lavieen
• PicoAlex
• PicoAndy
• PicoCare
• Sandro Dual
• Pastelle PRO
• Tightan
• V-Laser
• HOLINWON PRO
• HOLINWON PRIMA
• VeinCare
• PETRA & LIME
• ELLISE

Quantifiable outcome

• 71.1% gross margin in Q1 2026, up from 64.2% year prior
• +3 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability1 record

Feature8 records

Partnerships

Four partnerships are on record, tiered minor.

• Korean National Medical CenterminorStrategic or Co-development Partner · 30 April 2026Clinical training partnership with Korean National Medical Center for Global Proctor ship Program; Dr. Kim Woo-sik leading training on VeinCare 1940 endovenous laser ablation procedures.
• Chanhee Surgery ClinicminorStrategic or Co-development Partner · 30 April 2026Clinical training partnership with Dr. Park In-soo for EVLA training using Holinwon equipment as part of Global Proctor ship Program for international physicians.
• Major Korean Cosmetics ODM ManufacturersminorStrategic or Co-development Partner · 1 January 2026Collaboration with leading Korean cosmetics ODM manufacturers for medical skincare product development under Oligio Home brand.
• Sheep Medical (Japan)minorStrategic or Co-development Partner · 1 January 2024Strategic investment in Japanese medical company Sheep Medical; collaboration with Japanese hospital network for market development in Japan.

Scale indicators11 records

Recent moves14 records

Expansion highlights6 records

Direct peers

• Cynosure (Hologic): US-based developer of light-based aesthetic systems including RF, picosecond and hair-removal platforms; competes head-to-head with Wontech's Oligio, Picocare and Sandro Dual lines globally.
• Cutera: US aesthetic device company with RF (TruBody/TruSculpt) and laser platforms; competing for the same US aesthetic-clinic capital-equipment budgets as Wontech's Oligio X.
• InMode: Israeli aesthetic device maker specializing in RF, IPL and laser platforms for body contouring and skin; competes with Wontech in the physician-office aesthetic capital-equipment segment.
• Lumenis (Boston Scientific): Pioneer in medical and aesthetic laser systems including holmium surgical lasers (urology) and aesthetic platforms — directly comparable to Wontech's Holinwon surgical and Lavieen/Pastelle aesthetic franchises.
• Lutronic: South Korean aesthetic and surgical laser/energy-based device maker with overlapping product categories (RF, picosecond, thulium, Q-switched, holmium). Most direct Korean competitor in professional aesthetics.
• Jeisys Medical: Korean competitor in energy-based aesthetic devices (HIFU, RF, lasers); overlapping product mix and same domestic channel context, recruited into Wontech's recent senior hires.
• Alma Lasers: Global leader in energy-based medical and aesthetic devices across hair removal, skin rejuvenation, body contouring, and surgical applications — closest analog at scale and competitor in aesthetic RF, laser and HIFU categories.
• BTL Industries: Leading manufacturer of non-invasive body-contouring, skin-tightening and pelvic-health energy-based devices; competes with Wontech's RF and HIFU Oligio family in aesthetic clinics and MedSpas.

Emerging players

• Sciton: US-based privately held manufacturer of laser and light-based aesthetic and surgical platforms; overlaps with Wontech in aesthetic dermatology platforms and physician-channel GTM.

Broad incumbents

• Syneron Candela: Established global aesthetics incumbent offering a broad portfolio of laser, RF and IPL systems; competing portfolio overlap with Wontech across multiple product lines.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks7 records

Key highlights6 records

Customer concentration

• Xx.com/wtlaser
• Facebookfacebook.com/wtlaser

Compliance19 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Subsidiaries4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Wontech Co.